IL164267A0 - Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase - Google Patents

Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase

Info

Publication number
IL164267A0
IL164267A0 IL16426703A IL16426703A IL164267A0 IL 164267 A0 IL164267 A0 IL 164267A0 IL 16426703 A IL16426703 A IL 16426703A IL 16426703 A IL16426703 A IL 16426703A IL 164267 A0 IL164267 A0 IL 164267A0
Authority
IL
Israel
Prior art keywords
piperidinylamine
piperazinyl
inhibitors
acid amides
sulfamic acid
Prior art date
Application number
IL16426703A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0207500A external-priority patent/GB0207500D0/en
Priority claimed from GB0225679A external-priority patent/GB0225679D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL164267A0 publication Critical patent/IL164267A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL16426703A 2002-03-28 2003-03-27 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase IL164267A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0207500A GB0207500D0 (en) 2002-03-28 2002-03-28 Organic compounds
GB0225679A GB0225679D0 (en) 2002-11-04 2002-11-04 Organic compounds
PCT/EP2003/003214 WO2003082842A1 (en) 2002-03-28 2003-03-27 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase

Publications (1)

Publication Number Publication Date
IL164267A0 true IL164267A0 (en) 2005-12-18

Family

ID=28676499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16426703A IL164267A0 (en) 2002-03-28 2003-03-27 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase

Country Status (20)

Country Link
US (2) US7439362B2 (zh)
EP (1) EP1492782A1 (zh)
JP (1) JP4580652B2 (zh)
KR (1) KR20040094877A (zh)
CN (1) CN1293065C (zh)
AR (1) AR039156A1 (zh)
AU (1) AU2003226732B2 (zh)
BR (1) BR0308795A (zh)
CA (1) CA2480686A1 (zh)
CO (1) CO5640113A2 (zh)
IL (1) IL164267A0 (zh)
MX (1) MXPA04009453A (zh)
MY (1) MY136880A (zh)
NO (1) NO20044321L (zh)
NZ (1) NZ535617A (zh)
PE (1) PE20040167A1 (zh)
PL (1) PL372602A1 (zh)
RU (1) RU2329258C2 (zh)
TW (1) TW200306806A (zh)
WO (1) WO2003082842A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505541D0 (en) * 2005-03-17 2005-04-27 Novartis Ag Organic compounds
GB0505539D0 (en) * 2005-03-17 2005-04-27 Novartis Ag Organic compounds
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
CA2698814A1 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
JP2019507741A (ja) * 2016-02-08 2019-03-22 シンアフィックス ビー．ブイ． 治療において使用するためのスルファミドリンカーを含むバイオコンジュゲート
EP3413922A1 (en) 2016-02-08 2018-12-19 SynAffix B.V. Improved sulfamide linkers for use in bioconjugates
CN109069658B (zh) 2016-02-08 2022-10-14 西纳福克斯股份有限公司 用于靶向her2肿瘤的具有改善的治疗指数的抗体-缀合物以及用于改善抗体-缀合物的治疗指数的方法
WO2018102419A1 (en) * 2016-11-29 2018-06-07 Epizyme, Inc. Compounds containing a sulfonic group as kat inhibitors
US20220267300A1 (en) * 2019-06-12 2022-08-25 NodThera Limited Sulfonamide derivatives and uses thereof
CN110590896B (zh) * 2019-11-04 2022-08-30 上海高准医药有限公司 雌酚酮硫酸酯哌嗪的制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US51547A (en) * 1865-12-19 Improvement in guide and tuck-marker for sewing-machines
US183459A (en) * 1876-10-17 Improvement in hinges
US478328A (en) * 1892-07-05 Glass-heating oven
US89089A (en) * 1869-04-20 Improved car-coupling
US71516A (en) * 1867-11-26 William b
US876846A (en) * 1907-05-28 1908-01-14 Stephen W Smith Road-machine.
US1122242A (en) * 1912-05-13 1914-12-29 Sanitary Can Company Can-body-feeding device.
US2103610A (en) * 1935-04-30 1937-12-28 Sofal Ltd Alloy steels
DE876846C (de) * 1943-06-01 1953-05-18 Bayer Ag Verfahren zur Herstellung von Abkoemmlingen des Sulfondiamids
US3004487A (en) * 1959-12-07 1961-10-17 Bank Of America Nat Trust & Savings Ass Imprinters
GB1593609A (en) 1978-01-31 1981-07-22 Christiaens Sa A Pyridine sulfonamides
FR2510106A1 (fr) 1981-07-27 1983-01-28 Rhone Poulenc Agrochimie Composes herbicides derives d'acides phenoxybenzoiques, et leurs procedes de preparation et d'utilisation
DK101683A (da) * 1982-03-12 1983-09-13 Duphar Int Res Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors
US5256632A (en) 1990-05-30 1993-10-26 Bayer Aktiengesellschaft Herbicidal sulphonylated carboxamides
IL99537A (en) 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
FR2716882B1 (fr) 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
FR2716883B1 (fr) 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
US5464788A (en) 1994-03-24 1995-11-07 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5783582A (en) 1994-07-20 1998-07-21 Merck & Co., Inc. Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone
WO1996010559A1 (en) 1994-10-04 1996-04-11 Fujisawa Pharmaceutical Co., Ltd. Urea derivatives and their use as acat-inhibitors
WO1997020820A1 (en) 1995-12-01 1997-06-12 Novartis Ag Heteroaryl compounds
DE19621483A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621482A1 (de) 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
ATE384048T1 (de) 1998-09-22 2008-02-15 Astellas Pharma Inc Cyanophenyl-derivate
CA2362778A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
JP2003500390A (ja) 1999-05-24 2003-01-07 シーオーアール セラピューティクス インコーポレイテッド Ｘａ因子阻害剤
JP4320089B2 (ja) * 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
EA005677B1 (ru) 2000-05-04 2005-04-28 Басф Акциенгезельшафт Гетероциклилзамещенные фенилсульфамоилкарбоксамиды
BR0210391A (pt) * 2001-06-12 2004-06-15 Elan Pharm Inc Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
ATE319703T1 (de) 2001-07-02 2006-03-15 Piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen

Also Published As

Publication number Publication date
AU2003226732B2 (en) 2006-12-21
CO5640113A2 (es) 2006-05-31
MY136880A (en) 2008-11-28
CN1293065C (zh) 2007-01-03
PL372602A1 (en) 2005-07-25
US20060052393A1 (en) 2006-03-09
RU2329258C2 (ru) 2008-07-20
NO20044321L (no) 2004-10-12
US7439362B2 (en) 2008-10-21
EP1492782A1 (en) 2005-01-05
MXPA04009453A (es) 2005-01-25
NZ535617A (en) 2006-04-28
BR0308795A (pt) 2005-01-18
JP4580652B2 (ja) 2010-11-17
KR20040094877A (ko) 2004-11-10
PE20040167A1 (es) 2004-05-26
AU2003226732A1 (en) 2003-10-13
CA2480686A1 (en) 2003-10-09
AR039156A1 (es) 2005-02-09
US20090042899A1 (en) 2009-02-12
JP2005526812A (ja) 2005-09-08
WO2003082842A1 (en) 2003-10-09
RU2004131822A (ru) 2005-07-10
TW200306806A (en) 2003-12-01
CN1646509A (zh) 2005-07-27

Similar Documents

Publication Publication Date Title
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
PL375877A1 (en) Hydantoine derivatives and their use as tace inhibitors
HK1079811A1 (en) Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter
IL165910A0 (en) Compositions of hyaluronic acid and methods of use
PL376301A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
HK1080069A1 (zh) 環氧酶2-抑制劑的硝酰氧基衍生物
PL377696A1 (pl) Enancjomery pochodnych kwasu tiofenohydroksamowego i ich zastosowanie jako inhibitorów HDAC
AU2003211093A8 (en) Inhibitors of rgs proteins
AU2003291867A8 (en) Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
IL164645A0 (en) Polymorph of 4-Ä2-Ä1-(2-ethoxyethyl)-1H-benzidimazole-2-YLÜ-1-piperidinylÜethylÜ-??-dimethyl-benzenoacetic acid
IL164267A0 (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
IL160786A0 (en) Acylsulfonamides as inhibitors of steroid sulfatase
PL371217A1 (en) Inhibitors of integrin alphavbeta6
IL163959A (en) Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them
TWI340160B (en) Organic acid containing compositions and methods for use thereof
IL155908A0 (en) Method of measuring low impedances
EP1633328A4 (en) METHOD AND COMPOSITION FOR STABLE AND CONTROLLED ADMINISTRATION OF (-) - HYDROXYCITRIC ACID
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
HK1063627A1 (en) New mandelic acid derivative and its use as thrombin inhibitors
AU2003258941A8 (en) Metalloproteinase inhibitors and intermediates for preparation thereof
ZA200407853B (en) Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
GB0230240D0 (en) Removal of an acid
AU2003277878A1 (en) Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
AU2003242559A8 (en) Alkylaminosiloxanes as corrosion inhibitors
SG107315A1 (en) Use of conjugated linoleic acid derivatives